Beclometasone dipropionate

Jump to: navigation, search
Beclometasone-dipropionate-2D-skeletal.png
Beclometasone dipropionate
Systematic (IUPAC) name
[2-[(8S,9S,10S,11S,13S,14S,16S,17R)-9-chloro-
11-hydroxy-10,13,16-trimethyl-3-oxo-
17-propanoyloxy-6,7,8,11,12,14,15,16-
octahydrocyclopenta[a]phenanthren-17-yl]-
2-oxo-ethyl] propanoate
Identifiers
CAS number 4419-39-0
ATC code A07EA07 D07AC15R01AD01R03BA01
PubChem 21700
DrugBank APRD00564
Chemical data
Formula C28H37ClO7 
Mol. mass 521.042 g/mol
Pharmacokinetic data
Bioavailability Converted to beclometasone-17-monopropionate (17-BMP) during absorption
Protein binding 87% of 17-BMP to albumin and transcortin
Metabolism By esterase enzymes found in most tissues
Half life 2.8 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

B3(AU)

Legal status

Pharmacy Only (S2)(AU) POM(UK)

Routes Oral & nasal inhalation, topical

WikiDoc Resources for

Beclometasone dipropionate

Articles

Most recent articles on Beclometasone dipropionate

Most cited articles on Beclometasone dipropionate

Review articles on Beclometasone dipropionate

Articles on Beclometasone dipropionate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Beclometasone dipropionate

Images of Beclometasone dipropionate

Photos of Beclometasone dipropionate

Podcasts & MP3s on Beclometasone dipropionate

Videos on Beclometasone dipropionate

Evidence Based Medicine

Cochrane Collaboration on Beclometasone dipropionate

Bandolier on Beclometasone dipropionate

TRIP on Beclometasone dipropionate

Clinical Trials

Ongoing Trials on Beclometasone dipropionate at Clinical Trials.gov

Trial results on Beclometasone dipropionate

Clinical Trials on Beclometasone dipropionate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Beclometasone dipropionate

NICE Guidance on Beclometasone dipropionate

NHS PRODIGY Guidance

FDA on Beclometasone dipropionate

CDC on Beclometasone dipropionate

Books

Books on Beclometasone dipropionate

News

Beclometasone dipropionate in the news

Be alerted to news on Beclometasone dipropionate

News trends on Beclometasone dipropionate

Commentary

Blogs on Beclometasone dipropionate

Definitions

Definitions of Beclometasone dipropionate

Patient Resources / Community

Patient resources on Beclometasone dipropionate

Discussion groups on Beclometasone dipropionate

Patient Handouts on Beclometasone dipropionate

Directions to Hospitals Treating Beclometasone dipropionate

Risk calculators and risk factors for Beclometasone dipropionate

Healthcare Provider Resources

Symptoms of Beclometasone dipropionate

Causes & Risk Factors for Beclometasone dipropionate

Diagnostic studies for Beclometasone dipropionate

Treatment of Beclometasone dipropionate

Continuing Medical Education (CME)

CME Programs on Beclometasone dipropionate

International

Beclometasone dipropionate en Espanol

Beclometasone dipropionate en Francais

Business

Beclometasone dipropionate in the Marketplace

Patents on Beclometasone dipropionate

Experimental / Informatics

List of terms related to Beclometasone dipropionate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Beclometasone dipropionate (INN modified) or beclomethasone dipropionate (USAN, former BAN), also referred to as beclometasone (INN), is a potent Class A glucocorticoid steroid drug. In the form of an inhaler (e.g. Becotide), a wide number of brands of which are available, it is used for the prophylaxis of asthma. As a nasal spray (e.g. Beconase, Vancenase), it is used for the treatment of rhinitis (e.g. hayfever) and sinusitis. In some instances it is used by oral pathologists in the treatment of unusually severe canker sores.

As a cream or ointment (trade name Propaderm) it is used to treat severe inflammatory skin disorders (e.g. eczema) unresponsive to less potent steroids, but is generally avoided in the treatment of psoriasis due to the risk of rebound on withdrawal.

Chemistry

It is a white to creamy-white, odorless powder which is very slightly soluble in water, very soluble in chloroform, and freely soluble in acetone and in ethanol.

Side effects

Occasionally it may cause a cough upon inhalation. Deposition on the tongue and throat may promote oral candidiasis which appears as a white coating, possibly with irritation.[1][2][3] This may usually be prevented by rinsing the mouth with water after using the inhaler. Other side effects may rarely include unpleasant taste, hoarseness or nasal congestion, pain or headache and visual changes. Allergic reactions rarely may occur.

As a steroid, it can also cause occurrences of retina detachments, by triggering Central Serous Retinopathy.

Footnotes

  1. Willey R, Milne L, Crompton G, Grant I (1976). "Beclomethasone dipropionate aerosol and oropharyngeal candidiasis.". Br J Dis Chest 70 (1): 32-8. PMID 1259918.
  2. Salzman G, Pyszczynski D (1988). "Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber.". J Allergy Clin Immunol 81 (2): 424-8. PMID 3339197.
  3. Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S (2003). "Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone.". Ann Allergy Asthma Immunol 90 (6): 646-51. PMID 12839324.



de:Beclometason



Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox